The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis : A Critique of the Evidence

Sideris, Eleftherios, Corbett, Mark Stephen orcid.org/0000-0002-5937-1493, Palmer, Stephen John orcid.org/0000-0002-7268-2560 et al. (2 more authors) (2016) The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis : A Critique of the Evidence. Pharmacoeconomics.. 1101–1110.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Springer International Publishing Switzerland 2016. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.
Dates:
  • Accepted: 20 May 2016
  • Published (online): 8 June 2016
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
Depositing User: Pure (York)
Date Deposited: 18 Jul 2016 09:23
Last Modified: 29 Aug 2019 23:13
Published Version: https://doi.org/10.1007/s40273-016-0419-7
Status: Published online
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-016-0419-7
Related URLs:

Download

Filename: Apremilast_Pharmacoeconomics_paper_17052016_clean.docx

Description: Apremilast_Pharmacoeconomics_paper_17052016_clean

Share / Export

Statistics